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Motivation

Design Scheme

Results and Discussion
Syringe

Currently, when the R&D team
at Pfizer wishes to test new
formulations of material in gel
capsules, they must use the
large-scale
machine
that
requires a minimum of 25 kg of
gel melt and produce hundreds
of
capsules
per
run.
Production at a smaller scale
to enable rapid changeover for
research and development is
desired.

Project Aims
The focus of the 2016-2017
team has been automated
production of sealed capsules
from premade gelatin ribbons.
The specific objectives are to:
• Design and implement
localized heating system to
promote capsule sealing
• Automate production of
sealed capsules
• Achieve liquid filled
capsules with 80% of the
maximum fill capacity
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Preliminary testing with a 3D
prototype indicated the
minimum hw = 0.9 ± 0.1 cm.
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Sealing efficiency (# of capsules sealed/total # of capsules) was measured at
• Td = 42°C, hw = 0.9 ± 0.1 cm, wm = 2.69 mL/min for 2 seconds with a down
time of 9 seconds
• Varied Tw, from 31.0 to 55.0 °C , wd = 0.33- 0.72 RPM to produce 2-4
capsules/min
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The parameters of interest were:
• Td - die roll temperature
• Tw - wedge temperature
• hw - wedge height
• wd - rotational rate of die rolls
• wm - timing/amount of liquid injected

Tw = 46-54 °C – air filled

Tw = 30-36 °C – injected

Tw = 38-44 °C – injected

Tw = 46-54 °C – injected

In general, capsules formed without injection sealed better than those with
injection.
• The optimal wedge surface temperature for sealing was 38-42 °C.
• Capsule sealing efficiency was highest at a rate of 4 capsules/min (0.72
RPM). For air filled capsules, a sealing efficiency of 100% was achieved. For
capsules injected with model fluid, a sealing efficiency of 50% was achieved.

Fin efficiency and convective heat transfer calculations were performed to
verify the heated wedge would promote gelatin sealing.
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Conclusions and Future Work
• Sealed, filled capsules were produced continuously at a rate of 4
capsules per minute
• Next steps are to integrate and automate gelatin feed system
• To increase the fill amount, incorporate a vacuum system at the point
of capsule formation
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